Denis Chem Lab Ltd (537536) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 537536 | NSE: | Pharmaceuticals & Drugs | Small Cap

Denis Chem Lab Share Price

85.50 0.57 0.67%
as on 05-Dec'25 12:03

Denis Chem Lab Ltd (537536) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 537536 | NSE: | Pharmaceuticals & Drugs | Small Cap

DeciZen - make an informed investing decision on Denis Chem Lab

Based on:

Overall Rating
Login to view analysis. M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality


Login to view analysis.

2. Valuation


Login to view analysis.

3. Price Trend


Login to view analysis.

Denis Chem Lab stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
16.48
Market Cap:
117.9 Cr.
52-wk low:
82.2
52-wk high:
193

Is Denis Chem Lab Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Denis Chem Lab: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Denis Chem Lab Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 5.3%12.2%9.4%11.9%11.3%6.5%13.8%16.1%20.2%13.9%-
Value Creation
Index
-0.6-0.1-0.3-0.2-0.2-0.50.00.20.40.0-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 99.6113107124136109137161168173174
Sales YoY Gr.-13.8%-5.4%15.8%9.7%-19.7%24.9%17.8%4.3%3.3%-
Adj EPS -4.70.91.64.131.64.55.785.85.2
YoY Gr.-NA80.2%149.4%-25.9%-45.9%174.4%25.8%42.1%-27.7%-
BVPS (₹) 1324.13640.742.644.347.952.157.961.363.2
Adj Net
Profit
-4.51.12.35.74.22.36.37.911.28.17
Cash Flow from Ops. 20.96.810.6813.4817.116.317.812.1-
Debt/CF from Ops. 2.15.52.42.911.10.20.10.10.1-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 6.3%4.9%8.3%3.3%
Adj EPS NA13.9%8.9%-27.7%
BVPS18.8%7.6%8.6%5.9%
Share Price -0.7% 13.1% -0.4% -49.9%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
-274.95.710.77.33.89.811.314.69.88.3
Op. Profit
Mgn %
8.512.311.411.2119.410.511.712.79.38.6
Net Profit
Mgn %
-4.512.14.63.12.14.64.96.74.74.1
Debt to
Equity
3.51.30.50.40.20.10.10000
Working Cap
Days
122114146139131157123103999878
Cash Conv.
Cycle
4624365366805944403747

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Denis Chem Lab Ltd.

Standalone Consolidated
TTM EPS (₹) 5.2 -
TTM Sales (₹ Cr.) 174 -
BVPS (₹.) 63.2 -
Reserves (₹ Cr.) 74 -
P/BV 1.34 -
PE 16.48 -
From the Market
52 Week Low / High (₹) 82.15 / 193.00
All Time Low / High (₹) 16.26 / 232.90
Market Cap (₹ Cr.) 118
Equity (₹ Cr.) 13.9
Face Value (₹) 10
Industry PE 40.7

Management X-Ray of Denis Chem Lab:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Denis Chem Lab - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Denis Chem Lab

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales100113107124136109137161168173
Operating Expenses 91999511012199122142147157
Manufacturing Costs8101011141012151515
Material Costs52534961625572848796
Employee Cost 913912121112131415
Other Costs 21242725332326293031
Operating Profit 8141214151014192116
Operating Profit Margin (%) 8.5%12.3%11.2%11.2%11.0%9.4%10.5%11.7%12.7%9.3%
Other Income 0112001112
Interest 7653321111
Depreciation 6766766877
Exceptional Items 0000000000
Profit Before Tax -3226639111511
Tax 11-0-0213343
Profit After Tax -41264268118
PAT Margin (%) -4.5%1.1%2.0%5.1%3.1%2.1%4.6%4.9%6.6%4.7%
Adjusted EPS (₹)-4.71.01.54.63.01.64.55.78.05.8
Dividend Payout Ratio (%)0%0%0%22%0%46%33%35%31%26%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 12305056596266728085
Share Capital 9121414141414141414
Reserves 3183643454853586671
Minority Interest0000000000
Debt363321191182111
Long Term Debt201795242100
Short Term Debt16161314850000
Trade Payables17202017181620182121
Others Liabilities 191110131078875
Total Liabilities 859410110697929699109112

Fixed Assets

Gross Block627475929495101102111119
Accumulated Depreciation22293541485459677481
Net Fixed Assets 40444050464142353839
CWIP 10150000200
Investments 0000000000
Inventories6578991091010
Trade Receivables23323136353332313231
Cash Equivalents 37116459172526
Others Assets 4575444557
Total Assets 859410110697929699109112

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 21711813817161812
PBT -3226639111511
Adjustment 1312108976866
Changes in Working Capital 12-7-1-50-23-010
Tax Paid 0-0-0-1-2-1-1-2-4-5
Cash Flow From Investing Activity -13-1-16-2-2-1-10-11-15-8
Capex -13-2-8-9-2-2-5-5-7-8
Net Investments 01-86-00-5-7-9-1
Others -0000000011
Cash Flow From Financing Activity -7-01-5-14-6-7-4-4-4
Net Proceeds from Shares 016180000000
Net Proceeds from Borrowing -4-7-12-4-3-0-1-1-00
Interest Paid -7-6-5-3-3-2-1-1-1-1
Dividend Paid -0000-20-1-2-3-3
Others 4-4-02-6-4-4-0-0-0
Net Cash Flow 15-41-31-01-1-0

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)-30.415.865.3711.947.293.769.7911.3314.629.76
ROCE (%)5.312.199.3711.911.346.513.7916.0720.1513.89
Asset Turnover Ratio1.251.321.111.21.341.151.451.641.611.56
PAT to CFO Conversion(x)N/A75.51.333.2542.8321.641.5
Working Capital Days
Receivable Days8484106989511386726866
Inventory Days17172123232925222121
Payable Days8812615011110511289828381

Denis Chem Lab Ltd Stock News

Denis Chem Lab Ltd FAQs

The current trading price of Denis Chem Lab on 05-Dec-2025 12:03 is ₹85.50.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Denis Chem Lab stood at ₹117.8.
The latest P/E ratio of Denis Chem Lab as of 04-Dec-2025 is 16.48.
The latest P/B ratio of Denis Chem Lab as of 04-Dec-2025 is 1.34.
The 52-week high of Denis Chem Lab is ₹193.0 and the 52-week low is ₹82.15.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Denis Chem Lab is ₹173.7 ( Cr.) .

About Denis Chem Lab Ltd

Denis Chem Lab is a Public Limited Pharmaceutical Company incorporated in 1982. It started commercial production for sterile Intravenous injectibles in 1984. Since more than 30 years it has been actively delivering high quality sterile Intravenous injectibles and contributing in saving lives. It Manufactures and market sterile Intravenous injectibles in Both Glass and Plastic Bottles.

The company’s manufacturing facilities are located in a pollution free environment near Ahmedabad, Gujarat. The Manufacturing facilities are located on a land area of about 14000 sq. metres, the built up area for the manufacturing operations is about 7000 sq.m.

Its manufacturing facilities have been approved by the Foods and Drugs Control Administration Authority (FDCA), Gujarat & WHO GMP. It has also been approved by international bodies, includes FDCA Ivory Cost, Ministry of Health-Vietnam, Ministry of Health-Combodia.

Business area of the company

The company is engaged in the business of manufacturing of Pharmaceuticals Transfusion Solution in Bottles. It offers wide range of sterile intravenous injectables for human and veterinary consumption. The company’s product offerings comprise of various products sold across several states in India. It also exports sterile intravenous medicines to countries like Sri Lanka, Nepal, Combodia, Vietnam, Somalia, Ivory Cost etc. In addition to manufacturing its own products which it sells under its own brands, it does manufacture products on contract basis for third parties including certain multinational pharmaceutical companies who market such products under their own brands.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×